The journey to implement cancer genomic medicine (CGM) in oncology practice began in
the 1980s, which is considered the dawn of genetic and genomic cancer research. At the …

Advances in cancer research have revolutionized the way cancer is diagnosed and treated.
Any cancer is now known to be an amalgamation of many subtypes, each carrying its …

Approximately 1 in 2 Japanese people are estimated to be diagnosed with cancer during
their lifetime. Cancer still remains the leading cause of death in Japan, therefore the …

Genomic alterations are important biological markers for cancer diagnosis and prognosis,
disease classification, risk stratification, and treatment selection. Chromosomal microarray …

Abstract The Global Cancer Genomics Consortium (GCGC) is an international collaborative
platform that amalgamates cancer biologists, cutting-edge genomics, and high-throughput …

This study aimed to establish the Japanese Cancer Genome Atlas (JCGA) using data from
fresh frozen tumor tissues obtained from 5143 Japanese cancer patients, including those …

All cancers arise as a result of abnormalities occurring in the DNA sequence of cancer cells,
and we are now stepping into an era in which it is feasible to obtain the complete DNA …

This is an exciting time to be in cancer medicine. New technologies, such as next-generation
sequencing (NGS), have increased our understanding of the molecular aberrations that …

The Human Genome Project not only provided the essential reference map for the human
genome but also stimulated the development of technology and analytic tools to process …

Since June 2019, under the umbrella of the national health insurance system, Japan has
started cancer genomic medicine (CGM) with comprehensive genomic profiling (CGP) tests …